CRO & Clinical Services

Peapod Bio is a Chicago-based CRO specializing in biochemical assay development, high-throughput screening, and affinity selection mass spectrometry for small molecule and peptide drug discovery. Using label-free MALDI mass spectrometry, orthogonal optical assays, and curated small-molecule libraries, the company delivers rapid, high-quality data to support hit identification and early go/no-go decisions in diverse therapeutic areas.

Mettler Toledo is a global provider of precision instruments and services for laboratories and industry, widely used in pharmaceutical R&D and QC. Its portfolio includes analytical balances, titration, pH, and thermal analysis instruments, supported by lifecycle services for calibration, qualification, and regulatory compliance.

Phesi is a US-based clinical data science company providing AI-powered, patient-centric data analytics products and services to global biopharmaceutical companies. Using a patented AI platform and a large integrated clinical trials database, Phesi supports end-to-end clinical development planning, protocol design, site selection and trial implementation to optimize trial performance and accelerate drug development.

PhoreMost is a Cambridge, UK-based private biotech company focused on oncology, developing small molecule drugs and bifunctional degraders for cancers of high unmet clinical need. Its lead program PMC-001 targets primary and metastatic brain cancers, alongside additional HPV+ and degrader-based oncology assets, supported by proprietary chemistry against novel E3 ligases and active partnering opportunities.

Evotec is a global life science and biotechnology company providing integrated drug discovery, preclinical development, and biologics CDMO services from early target discovery through clinical development and commercial manufacturing. With multi-modality expertise, proprietary platforms, and its Just – Evotec Biologics continuous manufacturing platform, it supports pharma and biotech partners across oncology, metabolic, neurological, and immunology programs worldwide.

Plasmidsaurus is a sequencing-as-a-service provider offering ultrafast, high-accuracy DNA and RNA sequencing for plasmids, RNA-Seq, amplicons, whole genomes, AAV and microbiome samples. With global labs and dropboxes, integrated bioinformatics and simple online ordering, it helps pharma, biotech and diagnostics teams validate constructs, profile gene expression and characterize microbial or vector samples without in-house sequencing infrastructure.

Spectral Instruments Imaging, part of Bruker, manufactures high‑performance preclinical in vivo optical imaging systems for small animal research. Their Lago and Ami platforms offer bioluminescence, fluorescence and planar X‑ray imaging with high throughput, patented LED illumination, -90°C cooled cameras and Aura software for streamlined acquisition, kinetics and free multi‑station analysis. These solutions support oncology, translational medicine and immunotherapy programs and demanding imaging core workf

ProImmune is a UK-based biotechnology company specializing in immunology reagents and services that support basic, preclinical, and clinical research. Its portfolio includes Ankyrons next-generation binding reagents, MHC tetramers and pentamers, peptide pools, custom peptide synthesis, and comprehensive immunogenicity and immunotoxicology assay services for biotherapeutic and vaccine development.

debra of America is the U.S. 501(c)(3) nonprofit dedicated to Epidermolysis Bullosa (EB), a rare and severe genetic skin disorder. It provides free wound-care supplies, nurse education, family and legal support, mentorship, conferences and research funding, while partnering closely with treatment developers and clinical investigators to advance EB therapies and improve patient quality of life.

ProPharma is a global life sciences partner providing regulatory, clinical research (CRO), quality & compliance, pharmacovigilance, medical information, FSP and digital transformation services across the full product lifecycle. Focused on improving patient health and safety, it supports drugs, biologics, medical devices and diagnostics from early development through post-market. With over 25 years of experience, ProPharma offers customizable, end-to-end solutions for biotech, pharma and medtech sponsors wor

Biognosys (Proteomic Solutions) is a global leader in next-generation, mass spectrometry–based proteomics for pharma and biotech R&D and clinical development. It offers contract research services, advanced proteomics software, and peptide kits/reagents that enable deep, unbiased protein quantification across tissues and biofluids, supporting biomarker discovery, target validation, and precision medicine.

Protheragen Inc. is a New York–headquartered biopharmaceutical project incubator and investment platform focused on early-stage, first‑in‑class therapeutics. It offers project incubation, equity investment, and cross‑border BD consulting, managing a broad pipeline of antibody, protein, small molecule, cell and gene therapy programs across oncology, metabolic, inflammatory, and infectious disease indications. The company connects innovative assets with global partners to support licensing, co‑development, an

Provectus Algae is an Australian biotech company using its proprietary Precision Photosynthesis® and AI-enabled platform to industrially cultivate algae for climate-positive products. Its lead product, Surf’N’Turf®, is an Asparagopsis seaweed-based feed supplement for ruminants that improves feed digestibility and reduces enteric methane emissions by up to 98%. The company operates modular, automated algae production facilities and in‑house formulation capabilities to deliver stable, scalable, fit‑for‑purpo

Q2 Solutions is now IQVIA Laboratories, a global clinical trial laboratory services provider offering central lab, biomarker, genomics, bioanalytical, vaccine, and digital workflow services for pharmaceutical and biotech clinical trials.

Renaissance BioScience is a Vancouver-based bioengineering company that develops proprietary yeast-based technologies for food, beverage, agriculture, health, and specialty industrial markets. Using whole organism and gene-targeted engineering, it offers acrylamide-reducing and flavor-optimizing yeast strains, alongside RNAi biopesticide and wellness-oriented platforms, to deliver cleaner, smarter and more sustainable bio-based solutions.

Tangible Scientific (Research Logistics Automation) provides an AI-driven research operations platform that automates life science logistics, from compound storage and sample management to integrated ADME, chemistry, and analytical services. Using an API-first, software-centric architecture, it centralizes custody, improves data quality and provenance tracking, and reduces discovery cycle times for pharma and biotech R&D teams.

Resolve BioSciences is a private spatial biology company specializing in Molecular Cartography™ for high‑resolution, multi‑modal profiling of RNA, protein, and morphology in tissue. Its end‑to‑end platform, software, and services support oncology, immunology, and translational research teams in discovering spatial biomarkers, understanding tumor–immune interactions, and improving diagnosis and patient stratification.

Restek is a privately held, 100% employee-owned chromatography specialist headquartered in Bellefonte, Pennsylvania. It designs and manufactures GC/LC columns, accessories, sample preparation tools, air sampling products, and certified reference materials under ISO 9001–certified manufacturing in the US and Germany, serving pharmaceutical, environmental, food, petrochemical, and clinical laboratories worldwide.

SPT Labtech provides lab automation systems for liquid handling, sample preparation and sample management used in genomics, drug discovery and structural biology. With a focus on miniaturization, precision and throughput, its instruments help pharma and biotech labs reduce costs, improve reproducibility and scale high‑value research and screening workflows.

STEMCELL Technologies is a Canadian biotechnology supplier specializing in cell culture media, cell separation systems, primary cells, and organoid tools for stem cell, immunology, cancer, regenerative medicine, and cell therapy research. It combines reagents, instruments, and advanced cellular models with extensive training and scientific support, making it a key partner for pharma and biotech labs building robust cell-based assays and early cell therapy workflows.

Sannova Analytical is a New Jersey-based boutique CRO providing integrated CMC analytical and bioanalytical services from preclinical through Phase I–IV and commercialization. With advanced LC/MS/MS, TIMS, HPLC, ICP-MS, and stability infrastructure, it supports DMPK/TK, method development and validation, and QC/stability testing for complex, novel, and generic drugs. The company emphasizes quality, speed, flexibility, and close scientific collaboration.

Inventia Life Science provides advanced 3D cell culture platforms and scalable 3D cell models built around the RASTRUM technology for drug discovery, disease research, and toxicology. Its Validated Solutions, Discovery workflows, and RASTRUM Allegro system help labs generate reproducible, human-relevant in vitro data at scale for more confident program decisions.

Biotage Sweden AB is a global provider of separation, purification and workflow solutions for drug discovery, development and analytical testing labs. From peptide synthesis and plasmid DNA prep to automated sample preparation and chromatography, Biotage delivers instruments, consumables and application support to streamline and standardize modern pharmaceutical and analytical workflows.

Seven Bridges is a biomedical data and bioinformatics company providing cloud-based platforms, workflows, and analytics to accelerate genomics research and precision medicine across biopharma, healthcare, and public-sector programs. Its Seven Bridges Platform and products such as GRAF and the Cancer Genomics Cloud combine large genomic datasets, scalable compute, and secure collaboration tools to support biomarker discovery, clinical trial optimization, and population-scale genomics.